MFDS — authorised 20 November 2020
- Marketing authorisation holder: EIGER BIOPHARMACEUTICALS INC
- Status: likely_approved
MFDS authorised Zokinvy on 20 November 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 20 November 2020.
EIGER BIOPHARMACEUTICALS INC holds the South Korean marketing authorisation.